These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin]. Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S. Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528 [Abstract] [Full Text] [Related]
5. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy. Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT. Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649 [Abstract] [Full Text] [Related]
7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 Sep; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
8. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H. J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [Abstract] [Full Text] [Related]
9. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J. Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [Abstract] [Full Text] [Related]
14. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C. Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166 [Abstract] [Full Text] [Related]
15. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM, Sheen IS, Liaw YF. Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075 [Abstract] [Full Text] [Related]
16. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Med Sci Monit; 2000 Jun; 6(5):964-70. PubMed ID: 11208439 [Abstract] [Full Text] [Related]
17. Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4. El Sayed ZM, Mansour FA, Ghal MF, Abou-Zahra SB. Immunol Invest; 2011 Jun; 40(1):29-38. PubMed ID: 20809700 [Abstract] [Full Text] [Related]
18. Declining sustained virological response in hepatitis C. Batool U, Qureshi S. J Coll Physicians Surg Pak; 2006 Mar; 16(3):187-91. PubMed ID: 16542597 [Abstract] [Full Text] [Related]
20. Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan. Ali S, Ahmad B, Ali I, Mahmood N, Anwar N, Saeedi I, Afridi JZ. Asian Pac J Cancer Prev; 2016 Mar; 17(5):2407-10. PubMed ID: 27268605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]